Explore 3 Stock Ideas & Industry Insights Download Free Report

Stocks

Q1 2025 Archrock Inc Earnings Call

Participants Megan Repine; Vice President - Investor Relations; Archrock Inc Douglas Childers; President, Chief Executive Officer, Director; Archrock Inc Douglas Aron; Chief Financial Officer, Senior Vice President; Archrock Inc Jim Rollyson; Analyst; Raymond James Gab Moreen; Analyst; Mizuho Securities USA` Doug Irwin; Analyst; Citi …

EODHD | 07 May 2025

3 UK Growth Companies With High Insider Ownership And 20% Revenue Growth

The United Kingdom market has faced recent challenges, with the FTSE 100 and FTSE 250 indices experiencing declines amid concerns over weak trade data from China and its impact on global demand. In this environment, identifying growth companies with high insider ownership can be …

EODHD | 07 May 2025

BAE Systems Sticks to Guidance as Defense Spending Rises

The group doesn’t expect to be affected by U.S. tariffs on U.K. imports, since the vast majority of the equipment it sells to the U.S. is produced there. Continue Reading

EODHD | 07 May 2025

CREDIT AGRICOLE S.A. ANNOUNCES REDEMPTION OF EUR 750,000,000 Subordinated Fixed Rate Resettable Notes issued on June 5, 2020 (ISIN: FR0013516184)

CREDIT AGRICOLE SA Montrouge, May 7, 2025 CREDIT AGRICOLE S.A. ANNOUNCES REDEMPTION OF EUR 750,000,000 Subordinated Fixed Rate Resettable Notes issued on June 5, 2020 (ISIN: FR0013516184)* Crédit Agricole S.A. (the “Issuer”) announces today the redemption (the “Redemption”) with effect on June 5, 2025 …

EODHD | 07 May 2025

ENHERTU® Followed by THP Before Surgery Showed Statistically Significant and Clinically Meaningful Improvement in Pathologic Complete Response in Patients With High-Risk HER2 Positive Early-Stage Breast Cancer in DESTINY-Breast11 Phase 3 Trial

Daiichi Sankyo and AstraZeneca’s ENHERTU followed by THP showed an improved safety profile versus standard of care First phase 3 trial to demonstrate benefit of ENHERTU in early breast cancer Results will be shared with regulatory authorities TOKYO & BASKING RIDGE, N.J., May 07, …

EODHD | 07 May 2025

Final Data From the Phase 3 MYR301 Study Demonstrated Longer Treatment With Bulevirtide Was Associated With Sustaining Undetectability After Stopping Treatment

– 90% of Adults with Chronic Hepatitis Delta Virus (HDV) who Achieved Undetectable HDV RNA at 96 Weeks of Treatment with Bulevirtide Remained Undetectable for Almost 2 Years After Stopping Treatment – FOSTER CITY, Calif., May 07, 2025--(BUSINESS WIRE)--Gilead Sciences Inc. (Nasdaq: GILD) today …

EODHD | 07 May 2025

Monopar Presents ALXN1840 Late-Breaker Data at EASL 2025

WILMETTE, Ill., May 07, 2025 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing innovative treatments for patients with unmet medical needs, is presenting today data on the long term efficacy and safety of its ALXN1840 (tiomolybdate choline) …

EODHD | 07 May 2025

Fluidra Delivers Strong Start to 2025, with Sales up 7% to €564 Million and Growth Across All Regions

Positive volume, price and M&A contribution Simplification Program continues to drive margin expansion Signed two value-enhancing acquisitions of Aiper and PoolTrackr Confident in delivering full-year guidance despite ongoing geopolitical and macroeconomic uncertainty BARCELONA, Spain, May 07, 2025--(BUSINESS WIRE)--Fluidra, the global leader in equipment and …

EODHD | 07 May 2025

Weekly Picks: 🫣 DSP's Potential, VOLV's Bold Plans and DOCN's Tailwinds

Welcome to Weekly Picks, where each week our analysts hand pick their favourite Narratives from the community ( what is a Narrative? ). This week’s picks cover: 📺 Why Viant Technology is well positioned in the booming connected TV market, 🚘 How Volvo will …

EODHD | 07 May 2025

Q1 2025 WK Kellogg Co Earnings Call

Participants Karen Duke; Investor Relations; WK Kellogg Co Gary Pilnick; Executive Chairman of the Board, Chief Executive Officer; WK Kellogg Co Dave McKinstray; Chief Financial Officer; WK Kellogg Co Andrew Lazar; Analyst; Barclays Kenneth Goldman; Analyst; JP Morgan Megan Clap; Analyst; Morgan Stanley Peter …

EODHD | 07 May 2025
Support

Hi! How can we help you today?

Loading…